Celldex Therapeutics, Inc.CLDXNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-213.66M
↓ 107% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
$-103.28M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-213.66M | -33.8% |
| 2024 | $-159.70M | -46.4% |
| 2023 | $-109.11M | -3.4% |
| 2022 | $-105.56M | -69.8% |
| 2021 | $-62.16M | -48.2% |
| 2020 | $-41.96M | +11.0% |
| 2019 | $-47.15M | +38.0% |
| 2018 | $-76.05M | +25.2% |
| 2017 | $-101.72M | +12.1% |
| 2016 | $-115.79M | - |